About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Allergan India Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 cr and a paid-up capital of Rs 8.00 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Abbvie Therapeutics India Private Limited India is Perumal Chinnaiah as Company Secretary. Vidhan Kedia, Suresh Pattathil, Swati Piramal, and Four other members serve as directors at the Company.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U33201KA1994PTC023162 |
| Company No. | 023162 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 04 Jul 1994 |
| Date of AGM | 11 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Products or Services related to Abbvie Therapeutics India Private Limited
Vitamins, Minerals & Antioxidants
Financials of Abbvie Therapeutics India Private Limited
Abbvie Therapeutics India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.86% increase. The company also saw a slight improvement in profitability, with a 7.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.1%.
Corporate Structure
Unlock access to Abbvie Therapeutics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Abbvie Therapeutics India Private Limited
Unlock and access historical data on people associated with Abbvie Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
SP
Suresh Pattathil
Managing DirectorAppointment Date: 10-Jul-2020
Status: Current
PC
Perumal Chinnaiah Company SecretaryAppointment Date: 03-Nov-2021
Status: Current
Board Members(6)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abbvie Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbvie Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Piramal Glass Private Limited
Active
26 years 7 months Swati Piramal and Ajay Piramal are mutual person
Organisation Of Pharmaceutical Producers Of India
Active 58 years 8 months Suresh Pattathil is a mutual person
Piramal Enterprises Limited
Active 77 years 5 months Swati Piramal and Ajay Piramal are mutual person
Piramal Capital & Housing Finance Limited
Active 40 years 5 months Swati Piramal and Ajay Piramal are mutual person
Recent activity within the organization
Director Appointment
Hong Liu Shi was appointed as a Additional Director was appointed as a Additional Director on 01 Feb 2024 & has been associated with this company since 7 months 23 days .
01 Feb 2024Annual General Meeting
Abbvie Therapeutics India Private Limited last Annual general meeting of members was held on 11 Aug 2023 as per latest MCA records.
11 Aug 2023Balance Sheet
Abbvie Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Director Appointment
Vivek Valsaraj was appointed as a Director was appointed as a Director on 22 Feb 2022 & has been associated with this company since 2 years 7 months .
22 Feb 2022Director Appointment
Suresh Pattathil was appointed as a Managing Director was appointed as a Managing Director on 10 Jul 2020 & has been associated with this company since 4 years 2 months .
10 Jul 2020
Recent News, Updates & Announcement
Bain Capital Banks Massive Return on Cerevel Deal.The Wall Street Journal 08 Dec 2023
- AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz other generic players.
Fiercepharma 22 Nov 2023
- AbbVie and Calibr expand partnership to advance clinical assets.
Pharmaceutical Technology 27 Jul 2023
- Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma.
Cision 30 Jun 2023
Frequently asked questions
What is the Incorporation or founding date of Abbvie Therapeutics India Private Limited?
